Tissue-nonspecific Alkaline Phosphatase [EPC]

4687 reported adverse events

Drugs of this class: ASFOTASE ALFA

These side effects are most commonly reported by patients taking drugs of the Tissue-nonspecific Alkaline Phosphatase [EPC] class:

# Side effect Count
0 INJECTION SITE PAIN 504
1 INJECTION SITE ERYTHEMA 407
2 INJECTION SITE REACTION 384
3 FATIGUE 334
4 PAIN 328
5 BLOOD ALKALINE PHOSPHATASE INCREASED 266
6 PAIN IN EXTREMITY 229
7 ARTHRALGIA 226
8 INJECTION SITE BRUISING 204
9 INJECTION SITE SWELLING 184
See all common reactions for Tissue-nonspecific Alkaline Phosphatase [EPC]

Drugs of the Tissue-nonspecific Alkaline Phosphatase [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADMINISTRATION SITE DYSAESTHESIA 1 1.0000
1 PSEUDOFRACTURE 3 0.5000
2 VITAMIN B6 ABNORMAL 10 0.4762
3 VITAMIN B6 DECREASED 36 0.4138
4 ADENOSINE DEAMINASE ABNORMAL 1 0.2500
5 VITAMIN B6 INCREASED 19 0.2184
6 INJECTION SITE DEFORMATION 9 0.1957
7 HYPOPHOSPHATASIA 6 0.1538
8 BEHAVIOUR DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.1250
9 ADENOSINE DEAMINASE INCREASED 1 0.1000
See all enriched reactions for Tissue-nonspecific Alkaline Phosphatase [EPC]